Context Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTX and other ETFs, options, and stocks.About CNTX
Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers.
CNTX Key Statistics
Stock Snapshot
Context Therapeutics(CNTX) stock is priced at $2.34, giving the company a market capitalization of 223.27M. It carries a P/E multiple of -6.35.
As of 2026-05-06, Context Therapeutics(CNTX) stock has fluctuated between $2.31 and $2.45. The current price stands at $2.34, placing the stock +1.3% above today's low and -4.5% off the high.
Context Therapeutics(CNTX) shares are trading with a volume of 598.02K, against a daily average of 1.06M.
In the last year, Context Therapeutics(CNTX) shares hit a 52-week high of $3.62 and a 52-week low of $0.49.
In the last year, Context Therapeutics(CNTX) shares hit a 52-week high of $3.62 and a 52-week low of $0.49.
Analyst ratings
100%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.